Active	Status	Sponsor type	Region	Phase	Filter
2 Active 6 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
mizagliflozin (VGX-3235) / Vogenx
NCT05541939: Effect of Mizagliflozin on Postprandial Glucose and Insulin in Post-Bariatric Hypoglycemia Subjects	Completed	2	9	US	Mizagliflozin	Vogenx, Inc.	Postbariatric Hypoglycemia	02/23	02/23
NCT05721729: Effect of Mizagliflozin Repeat Dosing on Adverse Events and Postprandial Glucose Excursions	Active, not recruiting	2	15	US	Mizagliflozin, Placebo	Vogenx, Inc.	Postbariatric Hypoglycemia	05/24	05/25